Open the map

DanaherDHR

Life science tools · NYSE · USA

$217.46
Down 0.5% todayClose

Down 4.6% this year but +10.8% since June 26, ahead of the life science sector at +10.7%. Danaher supplies 3 mapped companies.

This year
−4.6%
1 year
+4.7%
P/E
37.3
P/S
5.9
P/B
2.8

Price vs the life science sector

since Jun 26DHRLife science sector, equal weight
Danaher (DHR) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. DHR: +10.8% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−10%0%+10%Jun 26AugSepOct 8DHR +10.8%Sector +10.7% Danaher (DHR) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. DHR: +10.8% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.−10%0%+10%Jun 26AugSepOct 8DHR+10.8%Sector+10.7%

Supply chain

3 customers
SUPPLIERS →→ CUSTOMERSNone mappedRegeneron (REGN)REGNRegeneron−0.3%Amgen (AMGN)AMGNAmgen−1.4%Eli Lilly (LLY)LLYEli Lilly−1.6%DHRDanaher Open the full chain →

About Danaher

Cytiva supplies the equipment biologics are made with; Cepheid runs molecular diagnostics. Danaher owns both, along with a wider set of life science instruments.

Theme exposure

Life science toolsBioprocessingDiagnostics exposureDiagnostics

Products

  • Bioprocessing (Cytiva)
  • Molecular diagnostics (Cepheid)
  • Life science instruments

Competitors

  • Thermo Fisher
  • Sartorius
  • Agilent

Risks

  • Cyclical bioprocessing demand
  • Customer inventory normalisation

Same segment: Life science tools

Instruments, reagents and equipment for research, development and production. Segment 5 of 8 in the Medicine, pharma & life science value chain.

Compare DHR

Side by side with the largest companies in the same segment.

See where Danaher sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →